2024 in Review: Milestones and Momentum
As 2024 draws to a close, Voima Ventures takes ...
Scaling Science and Sustainability: Voima Ventures Finalises Fund III, north from €100M.
Helsinki, Finland - Voima Ventures has announced the final ...
Voima Ventures Study Reveals: Leadership Gaps Persist Despite Diversity Wins
Helsinki, Finland – Voima Ventures, a Nordic DeepTech Venture ...
Voima Ventures Leads €4M Investment in Liquid Sun to generate Aviation Fuel and Pave the Way for Cleaner Skies
Helsinki, Finland. Voima Ventures is proud to announce our ...
Diversity Drives Innovation: An Interview with Voima Ventures’ Founder, Inka Mero
Helsinki, Finland As we prepare to launch our 2024 ...
Voima Ventures Strengthens Life Science Expertise and Presence in Sweden
Helsinki, Finland Voima Ventures is pleased to welcome Stina ...
Avenue Biosciences Raises $2.5M to Scale AI-Enhanced Protein Engineering
Helsinki, Finland Avenue Biosciences, a transatlantic biotechnology company specialising ...
First-of-its-Kind NAD Testing: NADMED Raises €3.5M to Change Diagnostics
Helsinki, Finland - 22nd of August 2024. NADMED, a ...
Voima Ventures appoints a new female Partner, accelerating Nordic and Swedish expansion while advancing diversity
Stockholm, Sweden - 5th of June 2024. Today, Voima ...
ArgusEye Transforms Biopharma Manufacturing with Real-Time Inline Monitoring
Stockholm, Sweden - May 13th, 2024 - ArgusEye, an ...
